News Sentiment

PALI sentiment intelligence

Palisade Bio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 45 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.96 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

-6.7% over one week, +14.6% over four weeks, trend active, and below fair value.

Latest direct headline Positive

Palisade Bio director Robert Baltera Jr. purchases $88,698 in stock

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -6.7% Price reacting lower
Trend fit Trend active 14.6% over four weeks
Fair value -52.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 29
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
Stock Titan 8
GlobeNewswire 6
Investing.com Nigeria 5
Investing.com 4
TradingView 4
simplywall.st 3
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 30
Earnings 13
Deals and strategy 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-45 of 45